318 filings
Page 14 of 16
POS AM
594uk7
8 Mar 11
Prospectus update (post-effective amendment)
12:00am
10-K
k8kroe4im09t gi66l
7 Mar 11
Annual report
12:00am
S-3
aveifwjy6u
7 Mar 11
Shelf registration
12:00am
8-K
pu1qdtq5apcz85eowz
23 Feb 11
Anthera Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results and Operational Update
12:00am
S-8
vsrsf3m8wc75 qef
7 Feb 11
Registration of securities for employees
12:00am
8-K
7pyfgb
1 Feb 11
Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
12:00am
424B3
4f5ham6
19 Nov 10
Prospectus supplement
12:00am
EFFECT
pdyy629y5isqnrifzl1f
18 Nov 10
Notice of effectiveness
12:00am
CORRESP
o8z dfuc3o
17 Nov 10
Correspondence with SEC
12:00am
424B3
2ah0qb09
17 Nov 10
Prospectus supplement
12:00am
8-K
bf7sk
16 Nov 10
Other Events
12:00am
UPLOAD
vkaiggy 5n
12 Nov 10
Letter from SEC
12:00am
424B3
hpuel34nwd
4 Nov 10
Prospectus supplement
12:00am
EFFECT
x4i3d58sxj an
3 Nov 10
Notice of effectiveness
12:00am
8-K
8wknr5s
2 Nov 10
Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
12:00am
8-K
doh58mjw6rpqigf
22 Sep 10
Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
12:00am